GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of glycaemic control threads, summarised so you do not have to read them — 26 comments in the full submission. View in context.
319
c/t2dglp1·submitted 5 months ago by u/gentle_correction

three years of glycaemic control threads, summarised so you do not have to read them

Questionbranch of 6 comments

Confession thread, sort of. I went from 1.7mg to 0.25mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 7 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have early…

Read the full submission and all 26 comments →

This branch

6 comments, started 5 months ago
u/tomas_kimani9 points·5 months ago

This is correct. Hypo risk is real.

replysharereportpermalink
u/ingrid_correia4 points·5 months ago·edited

Maintenance for 7 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

replysharereportpermalink
u/graph_it_gary5 points·5 months ago

the 81 A1c trend is the answer

replysharereportpermalink
u/camila_sandvik13 points·5 months ago

Strongly agree. A1c matters as much as weight.

replysharereportpermalink
u/marisol_moreau10 points·5 months ago

I am going to push back on this slightly.

replysharereportpermalink
u/gentle_correctionOPnice about it5 points·5 months ago

the triglycerides change is the signal

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/t2dglp1
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/a1c_arcu/fasting_insulin_fu/gentle_correction
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →